Abstract
The incidence rate for primary liver cancer (PLC) was investigated in the Health Unit of Brescia (about 325,000 inhabitants), North Italy, in the 5-year period 1986–90, in order to ascertain whether there was a high risk for developing the disease in the area as suggested by mortality data. A total of 349 incident cases were observed (male: female ratio =3.4: 1), of which 182 (52.1%) were diagnosed through histology. The cumulative risk was about 5% and 1% in males and females, respectively. The crude incidence rates were 34.5/100,000 in males and 9.4/100,000 in females, and the age-standardized rates were the highest among all those observed in the 9 Italian areas covered by Cancer Registries. Although about half of the cases in males can be attributed to either chronic alcoholic disease or HBV infection or both, further research is needed to investigate the role of known risk factors for PLC in the Health Unit.
Similar content being viewed by others
References
Adami H-O, Hsing AW, McLaughlin JK, et al. Alcoholism and liver cirrhosis in the etiology of primary liver cancer. Int J Cancer 1992; 51: 898–902.
Andersen IB, Sorensen TIA, Prener A. Increase in incidence due to diagnostic drift: Primary liver cancer in Denmark, 1943–85. Br Med J 1991; 302: 437–440.
Breslow NE, Day NE. Statistical methods in cancer research. The design and analysis of cohort studies. Lyon: IARC Scientific Publications No. 82, 1987.
Capocaccia R, Farchi G. Mortality from liver cirrhosis in Italy: Proportion associated with consumption of alcohol. J Clin Epidemiol 1988; 4: 347–357.
Chiaramonte M, Stroffolini T, Caporaso N, et al. Hepatitis C virus infection in Italy; a multicentre seroepidemiological study. Ital J Gastroenterol 1991; 23: 555–558.
Cislaghi C, Decarli A, La Vecchia C, Laverda N, Mezzanotte G, Smans M. Data, statistics and maps on cancer mortality. Italy, 1975/1977. Bologna: Pitagora Ed., 1986.
Caporaso N, Romano M, Marmo R, et al. Hepatitis C virus infection as an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 1991; 12: 376–371.
Colombo M, de Franchis MD, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. New Engl J Med 1991; 325: 675–680.
Donato F, Nardi G, Bollani A, Jacquot L, Bonetti F. Cancer mortality in Brescia in the years 1975–1984. Igiene Moderna 1986; 86: 313–336 (in Italian).
Donato F, Rodella S, Chiesa R, Picoco C, Fiore Donati L, Nardi G. Incidence cases of primary liver cancer: proposal for the use of some standardized criteria in case definition. Eur J Cancer, in press.
Giusti G, Galanti B, Gaeta GB, Piccinnino F, Ruggiero G. HBsAg carriers among blood donors in Italy: a retrospective survey of data from 189 blood banks. Hepato-Gastroenterol 1981; 28: 96–98.
ISTAT: Movimento migratorio della popolazione residente — Anno 1991 (in Italian). Rome: ISTAT, Annuario 4, 1994.
La Vecchia C, Decarli A, Mezzanotte G, Cislaghi C. Mortality from alcohol related disease in Italy. J Epidemiol Comm Health 1986; 40: 257–261.
Levi C, Maisonneuve P, Filiberti R, La Vecchia C, Boyle P. Cancer incidence and mortality in Europe. Médecine Sociale et Préventive 1989; 34 (suppl. 2): s1-s84.
Levrero M, Tagger A, Balsano C, et al. Antibodies to hepatitis C virus in patients with hepatocellular carcinoma. J Hepatol 1991; 12: 60–63.
McMahon BJ, London T. Workshop on screening for hepatocellular carcinoma. J Natl Cancer Inst 1991; 83: 916–919.
Miettinen O. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 1974; 99: 325–332.
Muir CS, Waterhouse JAH, Mack TM, Powell J, Whelan S. Cancer incidence in five continents, Vol. V. Lyon: IARC Scientific Publication. No. 88, 1987.
Munoz N, Bosch X. Epidemiology of hepatocellular carcinoma. In: Okuda K, Ishak KG (eds). Neoplasms of the liver. Berlin: Springer Verlag 1990.
Simonetti RG, Cammà C, Fiorello F, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis: A case control study. Ann Intern Med 1992; 116: 97–102.
Stroffolini T. The descriptive epidemiology of primary liver cancer in Italy. Ital J Gastroenterol 1991; 23: 443–447
Stroffolini T, Chiaramonte M, Tiribelli C, et al. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: Relative risk and population attributable risk from a case-control study in Italy. J Hepatol 1992; 16: 360–363.
Stroffolini T, Pasquini P, Mele A, and Collaborating Group for Vaccination against Hepatitis B in Italy. HBsAg carriers among pregnant women in Italy: Results from the screening during a vaccination campaign against hepatitis B. Public Health 1988; 102: 329–333.
Tanaka K, Hirohata T, Koga S, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991; 51: 2842–2847.
Vall Mayans M, Calvet X, Bruix J, et al. Risk factors for hepatocellular carcinoma in Catalonia, Spain. Int J Cancer 1990; 46: 378–381.
Walsh B, Grant M. Public health implications of alcohol production and trade. WHO Offset Publication No. 88, Geneva: WHO, 1985.
Zanetti R, Crosignani P (eds). Cancer in Italy: Incidence data from Cancer Registries 1983–1987. Torino: Lega Italiana per la Lotta contro i Tumori, 1992.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chiesa, R., Donato, F., Portolani, N. et al. Primary liver cancer in a high-incidence area in North Italy: Etiological hypotheses arising from routinely collected data. Eur J Epidemiol 11, 435–442 (1995). https://doi.org/10.1007/BF01721229
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01721229